The Impact of Metabolic Status on Pain and Central Sensitization in Women With Lipedema: A Cross-Sectional Observational Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorMarmara University
About this trial
The aim of this study is to evaluate the effect of metabolic markers (HOMA-IR, triglyceride/HDL ratio, HbA1c, waist and hip circumference measurements, BMI, etc.) on pain and central sensitization in patients diagnosed with lipedema. The primary objective is to investigate the association between metabolic markers and central sensitization. The secondary objective is to assess the relationship between metabolic markers and pain intensity, pain phenotype, and functional status.
Eligibility criteria
Qualifiers
Being female and aged 18 years or older
Having chronic pain persisting for at least 3 months
Having sufficient cognitive ability to understand and respond to the assessment scales used in the study
Voluntarily agreeing to participate in the study and providing written informed consent
Disqualifiers
Presence of a history of malignancy, active infection, inflammatory rheumatic disease, or severe systemic disease
History of known neurological disorders (e.g., stroke, multiple sclerosis, epilepsy)
Diagnosis of severe psychiatric disorders (e.g., psychotic disorders, bipolar disorder)
Pregnancy or breastfeeding
Trial design
Treatments tested in this trial
- Not listed
Trial groups
59 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov